Akiko Watanabe

4PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions With the Antibody-Drug Conjugate Trastuzumab Deruxtecan.

|Oct 13, 2025
Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A/P-gp Modulators.

Akiko Watanabe, Noriko Okudaira, Masaya Tachibana

|Sep 08, 2021
Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Akiko Watanabe, Tomoko Ishizuka, Makiko Yamada

|Aug 20, 2021
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Akiko Watanabe, Tomoko Ishizuka, Makiko Yamada

Pageof 1

Frequent Collaborators

1 joint publications

Masaya Tachibana

1 joint publications

Katherine L Gill

1 joint publications

Kuan-Fu Chen

1 joint publications

Mailys De Sousa Mendes